ENDRA Life Sciences (NDRA) Non-Current Assets (2016 - 2026)

ENDRA Life Sciences (NDRA) has reported Non-Current Assets for 11 consecutive years, with $2.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Non-Current Assets rose 192.97% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $6.2 million (up 315.59% YoY), while the FY2025 annual figure was $2.9 million, up 201.06% from the prior year.
• Non-Current Assets advanced to $2.9 million in Q1 2026 per NDRA's latest filing, from $2.9 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $3.9 million in Q4 2022 and bottomed at -$4.7 million in Q3 2024.
• Historically, Non-Current Assets has averaged $1.2 million across 5 years, with a median of $1.1 million in 2023.
• Annual changes were most pronounced in 2022 — Non-Current Assets surged 398.99% — and 2024, when it slumped 492.79%.
• ENDRA Life Sciences' Non-Current Assets stood at $3.9 million in 2022, then slipped by 4.45% to $3.7 million in 2023, then plunged by 176.74% to -$2.9 million in 2024, then surged by 201.06% to $2.9 million in 2025, then advanced by 0.54% to $2.9 million in 2026.
• Business Quant data shows NDRA's Non-Current Assets at $2.9 million in Q1 2026, $2.9 million in Q4 2025, and -$557346.0 in Q3 2025.